리서치 & 클리핑

187420 HLB제넥스

4 min read

187420 HLB제넥스

기본 정보

  • 섹터: KOSDAQ:제조
  • 시가총액: 660억원 (2026-06-30 기준)
  • 첫 등장: — (마커 미등장)
  • 태그: 매크로/바이오헬스 · 바이오 · 효소 · 마이크로바이옴 · 재조합단백질 · 헬스케어소재
  • 네이버 금융: 🔗

기업개요

  • 동사는 2000년 한국생명공학연구원 스핀오프로 설립된 맞춤형 효소 및 바이오헬스케어 소재 전문 기업으로, 2015년 코스닥 특례상장함.
  • 미생물 디스플레이 기술과 재조합 단백질 분비발현 기술을 통해 산업용 효소와 바이오 헬스케어 소재를 개발하고 있음.
  • 주력 제품은 반도체/섬유 수처리용 카탈라제, GOS 제조용 락타아제, 화장품 소재 등을 제공하며, 뇌신경계질환 치료 신약 연구개발도 진행하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자전일 종가종가등락률시간외vol색깔smart외연금투투개그외
2026-08-141,9602,000🔴 +2.04%—×1.0🟢 외인+0.1억+0.1+0.0+0.1+0.0-0.2+0.0
2026-08-132,0051,960🔵 -2.24%—×0.5🔻 개인+0.0억+0.0+0.0-0.3+0.0+0.2+0.0
2026-08-121,9882,005🔴 +0.86%—×0.4🟢 외인+0.2억+0.2+0.0-0.2+0.0+0.0-0.0
2026-08-111,7701,988🔴 +12.32%—×3.5🟡 금투-1.1억-1.1+0.0+0.6+0.0+0.5+0.0
2026-08-101,6671,770🔴 +6.18%—×0.4🟢 외인+0.2억+0.2+0.0+0.0+0.0-0.2+0.0
2026-08-071,6501,667🔴 +1.03%—×0.4🔻 개인-0.1억-0.1+0.0-0.1+0.0+0.2+0.0
2026-08-061,6071,650🔴 +2.68%—×0.9🟡 금투-0.0억-0.0+0.0+0.1+0.0-0.0+0.0
2026-08-051,6001,607🔴 +0.44%—×0.4🟡 금투-0.0억-0.0+0.0+0.1+0.0-0.1+0.0
2026-08-041,4701,600🔴 +8.84%—×0.3🟢 외인+0.2억+0.2+0.0-0.0+0.0-0.2+0.0
2026-08-031,4391,470🔴 +2.15%—×0.4🟡 금투+0.0억+0.0+0.0+0.0+0.0-0.0+0.0
2026-07-311,3731,439🔴 +4.81%—×0.4🟢 외인+0.4억+0.4+0.0+0.0+0.0-0.4+0.0
2026-07-301,4231,373🔵 -3.51%—×0.4🟢 외인+0.3억+0.3+0.0-0.2+0.0-0.1+0.0
2026-07-291,5201,423🔵 -6.38%—×0.5🔻 개인+0.2억+0.2+0.0-0.6+0.0+0.4+0.0
2026-07-281,6121,520🔵 -5.71%—×0.2🟡 금투-0.2억-0.2+0.0+0.2+0.0-0.0+0.0
2026-07-271,6851,612🔵 -4.33%—×0.5🟡 금투-0.5억-0.5+0.0+0.7+0.0-0.1+0.0
2026-07-241,6571,685🔴 +1.69%—×1.7🔻 개인-1.2억-1.2+0.0+0.2+0.0+1.0-0.0
2026-07-231,5501,657🔴 +6.90%—×0.3🔻 개인-0.0억-0.0+0.0-0.0+0.0+0.1+0.0
2026-07-221,5701,550🔵 -1.27%—×0.5🟢 외인+0.1억+0.1+0.0+0.0+0.0-0.2+0.0
2026-07-211,6421,570🔵 -4.38%—×0.7🔻 개인-0.1억-0.1+0.0+0.0+0.0+0.2-0.1
2026-07-201,6821,642🔵 -2.38%—×0.3🟢 외인+0.2억+0.2+0.0-0.0+0.0-0.2+0.0
2026-07-161,9001,682🔵 -11.47%—×3.0⚫ 그외-0.1억-0.1+0.0+0.0+0.0+0.1+0.1
2026-07-151,4621,900🔴 +29.96%—×12.3🔻 개인-5.4억-5.4+0.0-0.1+0.0+5.5-0.1
2026-07-141,4691,462🔵 -0.48%—×0.9🟢 외인+0.4억+0.4+0.0-0.0+0.0-0.4-0.0
2026-07-131,4661,469🔴 +0.20%—×1.6🟢 외인+0.8억+0.8+0.0-0.3+0.0-0.6+0.0
2026-07-101,9081,466🔵 -23.17%—×10.0🟢 외인+1.7억+1.7+0.0+0.4+0.0-2.2+0.0
2026-07-091,9101,908🔵 -0.10%—×1.7🟢 외인+0.3억+0.3+0.0-0.1+0.0-0.2+0.0
2026-07-081,9801,910🔵 -3.54%—×0.3🟡 금투-0.0억-0.0+0.0+0.0+0.0-0.0+0.0
2026-07-071,9501,980🔴 +1.54%—×0.8🔻 개인-0.1억-0.1+0.0-0.0+0.0+0.1+0.0
2026-07-061,9721,950🔵 -1.12%—×0.5🟢 외인+0.1억+0.1+0.0-0.1+0.0-0.0+0.0
2026-07-031,9411,972🔴 +1.60%—×0.4🟢 외인+0.1억+0.1+0.0-0.1+0.0-0.0+0.0
2026-07-022,0251,941🔵 -4.15%—×0.2🔻 개인-0.3억-0.3+0.0-0.0+0.0+0.3+0.0
2026-07-012,0302,025🔵 -0.25%—×0.4🟡 금투-0.2억-0.2+0.0+0.3+0.0-0.1+0.0
2026-06-302,0152,030🔴 +0.74%—×0.2🟢 외인+0.1억+0.1+0.0-0.0+0.0-0.1+0.0
2026-06-291,9532,015🔴 +3.17%—×0.5🟢 외인+0.1억+0.1+0.0-0.1+0.0+0.0+0.0
2026-06-261,9851,953🔵 -1.61%—×0.7🟢 외인+0.1억+0.1+0.0-0.0+0.0-0.1-0.0
2026-06-252,0801,985🔵 -4.57%—×0.9🟢 외인+0.1억+0.1+0.0-0.1+0.0-0.0+0.0

일자별 사유 (최신 위)

2026-08-11

  • 사유: —
  • 섹터 컨텍스트: KOSDAQ:제조 (smart -1,951억)
  • 매크로 원인: 제약·바이오 개별 임상·허가 호재 잇따르며 급등 (통풍신약 3상 성공, 이상지질혈증제 허가 등) (높음)

2026-07-15

  • 사유: —
  • 섹터 컨텍스트: KOSDAQ:제조 (smart +1,144억)
  • 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)

백링크